A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients
Clinical trial NCT04200040 · UNKNOWN
Trial details
- NCT number
- NCT04200040
- Sponsor
- OrienGene Biotechnology Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-27
- Primary completion
- 2022-12-27
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.